Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BMP Sunstone Sees Larger Market Share From China Healthcare Reforms, PE Buy Out In The Works?

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - U.S.-listed Chinese pharmaceutical manufacturer and distributor BMP Sunstone reported a 25.8 percent increase in revenue in the second quarter compared to the same year-ago period, for $40.9 million in revenue. The company anticipates gaining market share from China's ongoing healthcare reforms, for which the Chinese government has pledged to invest $124 billion from 2009 to 2011

You may also be interested in...



Sanofi Expands China Footprint In OTC And Rx Markets With BMP Sunstone Acquisition

Sanofi-Aventis has gained a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys

Sanofi Expands China Footprint In OTC And Rx Markets With BMP Sunstone Acquisition

Sanofi-Aventis has gained a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys

China's BMP Sunstone Reports Higher Profits With Launch Of National Healthcare Reforms

HONG KONG - U.S.-listed Chinese pharmaceutical manufacturer and distributor BMP Sunstone reported record profits in 2010

Latest News
See All
UsernamePublicRestriction

Register

SC075599

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel